Evidence map›Paper›PMID 35679310›Full record

ArticlePloS one2022

Association between plaque vulnerability and neutrophil extracellular traps (NETs) levels: The Plaque At RISK study.

Judith J de Vries, Anouchska S A Autar, Dianne H K van Dam-Nolen, Samantha J Donkel, Mohamed Kassem, Anja G van der Kolk, Twan J van Velzen, M Eline Kooi, Jeroen Hendrikse, Paul J Nederkoorn and 4 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Exploring Neutrophil Extracellular Traps in Cardiovascular Pathologies: The Impact of Lipid Profiles, PAD4, and Radiation.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2025
    Article
  6. Review
  7. Neutrophil extracellular traps: a catalyst for atherosclerosis.Molecular and cellular biochemistry · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Judith J de VriesDepartment of Hematology, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-5007-2147
Anouchska S A AutarDepartment of Hematology, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Dianne H K van Dam-NolenDepartment of Radiology and Nuclear Medicine, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-4527-3876
Samantha J DonkelDepartment of Hematology, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Mohamed KassemDepartment of Radiology and Nuclear Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.
Anja G van der KolkDepartment of Radiology, Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Twan J van VelzenDepartment of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.
M Eline KooiDepartment of Radiology and Nuclear Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.ORCID 0000-0001-7562-5724
Jeroen HendrikseDepartment of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Paul J NederkoornDepartment of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.
Daniel BosDepartment of Radiology and Nuclear Medicine, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Aad van der LugtDepartment of Radiology and Nuclear Medicine, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Moniek P M de MaatDepartment of Hematology, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-7749-334X
Heleen M M van BeusekomDepartment of Experimental Cardiology, Erasmus MC Rotterdam, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-2930-1152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carotid atherosclerotic plaque rupture and its sequelae are among the leading causes of acute ischemic stroke. The risk of rupture and subsequent thrombosis is, among others, determined by vulnerable plaque characteristics and linked to activation of the immune system, in which neutrophil extracellular traps (NETs) potentially play a role. The aim of this study was to investigate how plaque vulnerability is associated with NETs levels. We included 182 patients from the Plaque At RISK (PARISK) study in whom carotid imaging was performed to measure plaque ulceration, fibrous cap integrity, intraplaque hemorrhage, lipid-rich necrotic core, calcifications and plaque volume. Principal component analysis generated a 'vulnerability index' comprising all plaque characteristics. Levels of the NETs marker myeloperoxidase-DNA complex were measured in patient plasma. The association between the vulnerability index and low or high NETs levels (dependent variable) was assessed by logistic regression. No significant association between the vulnerability index and NETs levels was detected in the total population (odds ratio 1.28, 95% confidence interval 0.90-1.83, p = 0.18). However, in the subgroup of patients naive to statins or antithrombotic medication prior to the index event, this association was statistically significant (odds ratio 2.08, 95% confidence interval 1.04-4.17, p = 0.04). Further analyses revealed that this positive association was mainly driven by intraplaque hemorrhage, lipid-rich necrotic core and ulceration. In conclusion, plaque vulnerability is positively associated with plasma levels of NETs, but only in patients naive to statins or antithrombotic medication prior to the index event.

Indexed as

Carotid StenosisExtracellular TrapsHydroxymethylglutaryl-CoA Reductase InhibitorsIschemic StrokePlaque, AtheroscleroticStrokeCarotid ArteriesFibrinolytic AgentsHemorrhageHumansLipidsMagnetic Resonance ImagingNecrosisRisk FactorsFibrinolytic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsLipids

Identifiers

PMID35679310
PMCPMC9182254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.